No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Monday's Pre-Market Session
Is Ocular Therapeutix (NASDAQ:OCUL) Weighed On By Its Debt Load?
Ocular Therapeutix to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
EyePoint Initiated at Buy by Citi on WAMD Drug Potential
BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $18
Ocular Therapeutix (OCUL) Receives a Buy From Bank of America Securities